Vyant Bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Vyant Bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q4 2022.
  • Vyant Bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $25.6M, a 17.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $25.6M +$3.81M +17.5% Dec 31, 2022 10-K 2023-03-31
Q4 2021 $21.8M +$11.9M +119% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $9.96M -$20.5M -67.4% Dec 31, 2020 10-K 2022-03-30
Q4 2019 $30.5M -$1.29M -4.05% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $31.8M +$4.7M +17.4% Dec 31, 2018 10-K 2020-05-29
Q4 2017 $27.1M -$11.6M -29.9% Dec 31, 2017 10-K 2019-04-16
Q4 2016 $38.6M +$7.46M +23.9% Dec 31, 2016 10-K 2018-04-02
Q4 2015 $31.2M +$6.62M +26.9% Dec 31, 2015 10-K 2017-03-23
Q4 2014 $24.6M +$5.26M +27.2% Dec 31, 2014 10-K 2016-03-10
Q4 2013 $19.3M +$2.36M +13.9% Dec 31, 2013 10-K 2015-03-16
Q4 2012 $16.9M Dec 31, 2012 10-K 2014-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.